Medicenna Therapeutics Corp
(MDNAF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,432 | 14,792 | 17,850 | 21,423 | 22,302 |
| Receivables | 917 | 847 | 1,937 | 1,019 | 1,089 |
| Other current assets | 625 | 685 | 459 | 420 | 564 |
| TOTAL | $12,973 | $16,324 | $20,247 | $22,862 | $23,955 |
| Non-Current Assets | |||||
| PPE Net | 4 | 10 | 13 | 15 | 18 |
| Intangibles | 36 | 36 | 37 | 38 | 40 |
| Other Non-Current Assets | 84 | 93 | 101 | 110 | 124 |
| TOTAL | $123 | $139 | $152 | $163 | $182 |
| Total Assets | $13,096 | $16,463 | $20,398 | $23,025 | $24,137 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,192 | 3,264 | 3,152 | 2,238 | 2,077 |
| TOTAL | $3,237 | $3,306 | $3,187 | $2,267 | $2,101 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,425 | 2,572 | 3,487 | 8,295 | 7,338 |
| TOTAL | $2,425 | $2,572 | $3,487 | $8,295 | $7,338 |
| Total Liabilities | $5,661 | $5,877 | $6,675 | $10,562 | $9,439 |
| Shareholders' Equity | |||||
| Common Shares | 91,638 | 91,263 | 83,583 | 83,059 | 83,442 |
| Retained earnings | -92,961 | -89,059 | -84,988 | -85,303 | -83,744 |
| Other shareholders' equity | 37 | 25 | 7,068 | 7,051 | 7,198 |
| TOTAL | $7,435 | $10,585 | $13,724 | $12,464 | $14,698 |
| Total Liabilities And Equity | $13,096 | $16,463 | $20,398 | $23,025 | $24,137 |